These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 31900257)
21. A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease? Vignesh P; Bhattad S; Singhal M; Singh S Rheumatol Int; 2016 Aug; 36(8):1191-3. PubMed ID: 27154559 [TBL] [Abstract][Full Text] [Related]
22. Epidemiology, clinical characteristics, and immediate outcome of Kawasaki disease: a population-based study from a tropical country. Mat Bah MN; Alias EY; Razak H; Sapian MH; Foo FH; Abdullah N Eur J Pediatr; 2021 Aug; 180(8):2599-2606. PubMed ID: 34086103 [TBL] [Abstract][Full Text] [Related]
23. The peculiarities of Kawasaki disease at the extremes of age: Two case reports. Mărginean CO; Meliţ LE; Mărginean MO Medicine (Baltimore); 2019 Oct; 98(42):e17595. PubMed ID: 31626134 [TBL] [Abstract][Full Text] [Related]
24. Kawasaki disease: part II. Complications and treatment. Bayers S; Shulman ST; Paller AS J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease. Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062 [TBL] [Abstract][Full Text] [Related]
26. A rare cause of facial nerve palsy in a young infant: Kawasaki disease. Orgun A; Karagöl C; Pamuk U; Gürsu HA; Çetin İ Turk J Pediatr; 2018; 60(4):433-435. PubMed ID: 30859770 [TBL] [Abstract][Full Text] [Related]
27. [Reply to questions regarding diagnosis and treatment of Kawasaki disease]. Wang HW Zhonghua Er Ke Za Zhi; 2006 May; 44(5):337-8. PubMed ID: 16780708 [No Abstract] [Full Text] [Related]
28. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794 [TBL] [Abstract][Full Text] [Related]
35. Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease. Higashi K; Terai M; Hamada H; Honda T; Kanazawa M; Kohno Y Circ J; 2007 Jul; 71(7):1052-9. PubMed ID: 17587710 [TBL] [Abstract][Full Text] [Related]
36. A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns. Sadeghi P; Izadi A; Mojtahedi SY; Khedmat L; Jafari M; Afshin A; Yarahmadi P; Hosseinali Beigi E BMC Infect Dis; 2021 Apr; 21(1):368. PubMed ID: 33874899 [TBL] [Abstract][Full Text] [Related]
37. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial). Tremoulet AH; Jain S; Kim S; Newburger J; Arditi M; Franco A; Best B; Burns JC Contemp Clin Trials; 2016 May; 48():70-5. PubMed ID: 27080929 [TBL] [Abstract][Full Text] [Related]
38. ATYPICAL KAWASAKI DISEASE. Ristovski L; Milankov O; Vislavski M; Savić R; Bjelica M Med Pregl; 2016; 69(1-2):53-7. PubMed ID: 27498535 [TBL] [Abstract][Full Text] [Related]